ICON’s Clinical Trial Tokenisation solution is delivered within an operating framework aligned to industry security and data privacy standards, and its corporate security and data protection ...

These actions could adversely impact ICON's future revenues, gross margin or both. In the first quarter of 2024, ICON registered an increase of 2.4% in direct cost.

Blackbaud BLKB recently announced that it was working on a new AI-powered, social impact reporting and storytelling solution — Impact Edge. Citing an independent, anonymous market research ...

As Icon continues to expand its global footprint to help more banks accelerate their payments transformation, Donal will draw on his experience to oversee the technical direction of IPF.